Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2015

Emotional eating phenotype is associated with central dopamine
D2 receptor binding independent of body mass index
Sarah A. Eisenstein
Washington University School of Medicine in St. Louis

Allison N. Bischoff
Washington University School of Medicine in St. Louis

Danuta M. Gradysa
Washington University School of Medicine in St. Louis

Jo Ann V. Antenor-Dorsey
Washington University School of Medicine in St. Louis

Jonathan M. Koller
Washington University School of Medicine in St. Louis

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Eisenstein, Sarah A.; Bischoff, Allison N.; Gradysa, Danuta M.; Antenor-Dorsey, Jo Ann V.; Koller, Jonathan
M.; Al-Lozi, Amal; Pepino, Marta Y.; Klein, Samuel; Perlmutter, Joel S.; Morelein, Stephen M.; Black, Kevin J.;
and Hershey, Tamara, ,"Emotional eating phenotype is associated with central dopamine D2 receptor
binding independent of body mass index." Scientific Reports. 5,11283. 1-12. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/3946

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Sarah A. Eisenstein, Allison N. Bischoff, Danuta M. Gradysa, Jo Ann V. Antenor-Dorsey, Jonathan M. Koller,
Amal Al-Lozi, Marta Y. Pepino, Samuel Klein, Joel S. Perlmutter, Stephen M. Morelein, Kevin J. Black, and
Tamara Hershey

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/3946

www.nature.com/scientificreports

OPEN

received: 03 December 2014
accepted: 21 May 2015
Published: 12 June 2015

Emotional Eating Phenotype is
Associated with Central Dopamine
D2 Receptor Binding Independent
of Body Mass Index
Sarah A. Eisenstein1,2, Allison N. Bischoff1, Danuta M. Gredysa1, Jo Ann V. AntenorDorsey1, Jonathan M. Koller1, Amal Al-Lozi1, Marta Y. Pepino3, Samuel Klein3,
Joel S. Perlmutter2,4,5,6,7, Stephen M. Moerlein2,8, Kevin J. Black1,2,4,5 & Tamara Hershey1,2,4
PET studies have provided mixed evidence regarding central D2/D3 dopamine receptor binding and
its relationship with obesity as measured by body mass index (BMI). Other aspects of obesity may be
more tightly coupled to the dopaminergic system. We characterized obesity-associated behaviors and
determined if these related to central D2 receptor (D2R) specific binding independent of BMI. Twentytwo obese and 17 normal-weight participants completed eating- and reward-related questionnaires
and underwent PET scans using the D2R-selective and nondisplaceable radioligand (N-[11C]methyl)
benperidol. Questionnaires were grouped by domain (eating related to emotion, eating related
to reward, non-eating behavior motivated by reward or sensitivity to punishment). Normalized,
summed scores for each domain were compared between obese and normal-weight groups and
correlated with striatal and midbrain D2R binding. Compared to normal-weight individuals, the
obese group self-reported higher rates of eating related to both emotion and reward (p < 0.001),
greater sensitivity to punishment (p = 0.06), and lower non-food reward behavior (p < 0.01). Across
normal-weight and obese participants, self-reported emotional eating and non-food reward behavior
positively correlated with striatal (p < 0.05) and midbrain (p < 0.05) D2R binding, respectively. In
conclusion, an emotional eating phenotype may reflect altered central D2R function better than
other commonly used obesity-related measures such as BMI.

Reward-related behavioral and neurocircuitry dysfunction may contribute to obesity1 and provide therapeutic targets for prevention and treatment of the disease. However, the role of striatal dopamine (DA)
signaling in human obesity remains unclear due to mixed results of PET/SPECT studies that assess
the relationship between body mass index (BMI) and D2/D3 DA receptor (D2/D3R) availability. Some
studies have found that striatal D2/D3R availability is lower in obesity and negatively correlates with
BMI2–4 while others find no difference5–7 or higher D2/D3R availability in obese versus normal weight
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Normal-weight

Obese

Gender Distribution
Ethnicity Distribution

4 men, 13 women 16
C, 1 AA

3 men, 19 women 11 C,
10 AA, 1 Bi*

Age (years)

28.5 (5.5), 21–39

Mean (SD), range
31.4 (6.3), 23–40

Education level (years)

16.6 (1.4), 14–19

15.1 (1.9)*, 12–18

Body Mass Index (kg/m2)

22.1 (2.0), 18.7–25.9

39.6 (5.2)***, 33.4–51

Beck Depression Inventory
II
IQ

3.3 (4.4), 0–15
113.0 (12.7), 87–131a

6.0 (6.1), 0–21
107.5 (12.3), 84–131

Table 1. Participant Characteristics C, Caucasian; AA, African American; Bi, Biracial *, p <  0.05, ***,
p <  0.001 relative to normal-weight group aData not available for 2 participants

individuals8 or with increasing BMI9. Using a highly specific and non-displaceable ligand, we found no
significant associations of D2 receptor subtype (D2R) binding with obesity or BMI10.
Differences in human obesity DA PET study findings may be due to several factors. For instance,
the study samples used have had different degrees of obesity, ranging from overweight (BMI 25.0-29.9
kg/m2)3,6,9 and mild Class I (BMI 30.0-34.9 kg/m2)3 obesity to more severe Class III (BMI ≥  40.0 kg/
m2)2,4,5,8–10 obesity. Obesity phenotype and DA signaling abnormalities may differ across classes of obesity1,6. To further complicate interpretation, most of these studies employed radioligands with important
limitations. Specifically, [11C]raclopride and [18F]fallypride do not distinguish between D2R and D3R11,
which are localized differently across the brain and may be functionally distinct12. Furthermore, these
radioligands are displaceable by DA, so D2/D3R availability measures are influenced by endogenous DA
release as well as by D2/D3R binding per se13–15.
Although BMI is not consistently correlated with D2/D3R availability16, behavioral aspects of obesity
may have a closer relationship to DA signaling. To address this issue and the limitations described above,
we assessed obesity-associated characteristics that may relate to DA signaling, such as emotion- and
reward-based eating and behavior motivated by non-food reward and sensitivity to punishment, in obese
and normal weight participants. We investigated whether these characteristics correlated with striatal
D2R using (N-[11C]methyl)benperidol ([11C]NMB), a PET radioligand DA D2 receptor antagonist that
is highly selective for D2R over D3R17 and other G-protein receptors and is not displaced by endogenous
DA release18. In addition, since novelty seeking behavior is associated with midbrain D2/D3R binding19,
we explored the relationship between midbrain D2R binding and obesity-associated behavior.

Methods

Participants. Participants included 17 normal-weight and 22 obese individuals (see Table 1). One

individual in the normal-weight group was slightly overweight (BMI =  25.9 kg/m2) but percent body fat
and other weight parameters met normal-weight criteria. Selected data from 15 participants from each
group were reported previously10. After an overnight fast (at least 8 hr), participants underwent comprehensive medical evaluation, routine blood tests, hemoglobin A1C, and an oral glucose tolerance test
(OGTT). Individuals with self-reported history of diabetes, A1C ≥  6.5%, or OGTT results that indicated
impaired fasting glucose, impaired oral glucose tolerance, or diabetes were excluded. Individuals were
also screened and excluded for IQ <  8020 (WASI), and conditions including parkinsonism, lifetime psychosis, mania, substance dependence, major depression, social phobia, eating disorders (including binge
eating disorder) and panic disorder by neurological examination and psychiatric interview (Structured
Clinical Interview for DSM-IV21). Current smoking and medications related to DA function were also
exclusionary. No participant had smoked tobacco during the past 11 mos. or used medications related to
DA function during the past month. All participants provided written informed consent. All procedures
were performed in accordance with the Declaration of Helsinki and approved by Washington University’s
Human Research Protection Office and Radioactive Drug Research Committee.

Questionnaires. During the day of the OGTT, immediately and 1 hr after which a light snack and
lunch were provided, respectively, participants completed questionnaires addressing DA-related constructs, or domains, of interest: 1) eating behavior related to emotion including avoidance of negative
affect; 2) eating behavior related to reward including craving for palatable foods and inability to limit
intake of sweet foods; 3) non-food reward behavior, including approach, sensitivity, motivation, and
expectancy for non-food reward stimuli; and 4) punishment avoidance including inhibition, sensitivity,
and expectancy. Self-report questionnaires or subscales of self-report questionnaires were included in
these different domains (Table 2) based on their descriptions in original manuscripts introducing and
validating the questionnaire. Scores for each questionnaire or subscale were converted into z-scores and
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Domain and Included Questionnaires

Normal-weight

Eating Related to Emotion

− 1.46 (1.86)

Obese
1.13 (2.72)**

Emotional Eating Scale total score (EES, Arnow et al.,
1995)

12.53 (13.13)

27.59 (18.95)**

Dutch Eating Behavior Questionnaire Emotional Scale
average score (DEBQ ES, van Strien et al., 1986)

1.60 (0.57)

2.51 (0.97)**

Sweet Taste Questionnaire Mood Altering Effects (STQ
MAE, Kampov-Polevoy et al., 2006) total score

17.82 (7.27)

23.82 (6.97) †

Eating Related to Reward

− 1.83 (1.83)

1.42 (1.90)***

6.00 (4.37)

15.09 (6.70)***

14.47 (5.97)

21.68 (5.45)***

Food Craving Inventory total of averaged scores (FCI,
White et al., 2002)

7.95 (2.48)

10.28 (2.05)**

Reward

Binge Eating Scale total score (BES, Gormally et al., 1982)
Sweet Taste Questionnaire Impaired Control over Eating
Sweets (STQ IC) total score

0.82 (2.22)

− 0.66 (.2.26)*

Behavioral Activation System (BAS) total score from BIS/
BAS (Carver and White, 1994)

41.71 (4.73)

37.48 (5.76)*

Reward expectancy total score from Generalized Reward
and Punishment Expectancy Scales (GRAPES, Ball and
Zuckerman, 1990)

8.71 (2.80)

7.24 (3.38)

Sensitivity to reward total score from Sensitivity to
Punishment and Reward Questionnaire (SPSRQ, Torrubia
et al., 2001)

8.53 (3.00)

8.62 (3.58)

43.47 (7.37)

41.57 (5.27)

Summed curious, reward dependency, and persistence
scores from Temperament and Character Inventory
(TCI-R, Cloninger et al., 1994)
Punishment
Behavioral Inhibition System (BIS) total score from BIS/
BAS
Punishment expectancy total score from GRAPES
Sensitivity to punishment total score from SPSRQ
Harm avoidance total score from TCI-R

− 1.02 (2.46)

0.82 (3.85)†

19.41 (3.45)

20.91 (4.33)†

6.35 (2.55)

7.43 (2.75)

6.76 (4.07)

9.45 (6.68)

10.76 (4.25)

13.68 (6.38)†

Table 2. Behavioral Domains. Normal-weight n = 17; Obese n = 21-22. Summed z-scores (S.D.) shown
for each domain. Average score (S.D.) shown for individual questionnaires. ***, **, *, p ≤  0.001, 0.01, 0.05
relative to normal-weight group. †, p =  0.06 relative to normal-weight group.

summed together with other measures included in the domain to yield final domain scores for each
individual.
The following questionnaires were included in the Eating Related to Emotion domain: The Emotional
Eating Scale22 (EES) assesses urge to eat due to negative emotion. The Dutch Eating Behavior ‘Emotional’
subscale23 (DEBQ ES) consists of summed self-ratings of tendencies to eat in response to both ‘diffuse’
(e.g., bored) and ‘clearly labeled’ (e.g., anger) emotions. The ‘mood-altering effect’ subscale of the Sweet
Taste Questionnaire24 (STQ MAE) assesses the degree to which eating sweet foods alters mood in a
positive manner.
The following questionnaires were included in the Eating Related to Reward domain: The Binge
Eating Scale25 (BES) assesses the degree to which one experiences binge eating, including behavior (e.g.,
eating in secret) and emotions that occur before and after a binge (e.g. lack of control). The ‘Impaired
control over eating sweets’ subscale of the STQ24 (STQ IC) is a measure of one’s ability to refrain from
eating sweets. We used the total score on the Food Craving Inventory26 (FCI) to measure general craving
for sweet and high-carbohydrate or fatty foods.
The following questionnaires were included in the Non-food Reward domain: The Behavioral
Activation System (BAS) portion of the BIS/BAS27 questionnaire consists of three subscales: drive,
fun-seeking and reward responsiveness. It is meant to measure BAS sensitivity. Individuals with stronger
BAS should be more sensitive and derive more pleasure upon exposure to reward cues28,29. The sensitivity to reward portion of the Sensitivity to Punishment and Sensitivity to Reward Questionnaire30
(SPSRQ) also assesses BAS functioning. The reward expectancy portion of the Generalized Reward and
Punishment Expectancy Scales31 measures optimism and expectancy of positive life events. The ‘curiosity behavior’, or novelty-seeking, dimension of the Temperament and Character Inventory32 (TCI-R)
reflects bias towards active novelty-seeking, impulsivity and approach towards reward cues. The ‘reward
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dependency’ dimension of the TCI reflects bias towards prosocial behavior and social approval. The
‘persistence’ dimension of the TCI reflects degree of perseverance despite fatigue and other obstacles.
The following questionnaires were included in the Punishment domain: The Behavioral Inhibition
System (BIS) portion of the BIS/BAS27 questionnaire measures BIS sensitivity. People with stronger
BIS sensitivity should be more sensitive to and experience greater anxiety in response to punishment
cues28,29. The punishment portions of the GRAPES31 and SPSRQ30 assess punishment expectancy and
sensitivity, respectively. The ‘damage avoidance’ section of the TCI-R32 assesses bias towards behavior
aimed at avoiding harm.

MRI and PET Acquisition. On a day separate from the day of the OGTT, participants underwent

MRI and 2 hr PET scans, which took place between 0900 and 1700. Methods for [11C]NMB synthesis,
MRI and PET scan acquisitions are described previously10. Each participant intravenously received 6.4 –
18.1 mCi containing <7.3 μ g unlabeled NMB. [11C]NMB purity was ≥96% and specific activity ≥1066
Ci/mmol (39 TBq/mmol). Since [11C]NMB is not displaceable by endogenous DA18, participants were
not asked to fast or otherwise modify their food intake on the night before or day of the scans.

ROI-based Analyses. The methods for our ROI-based analyses are described in Eisenstein et al.10,33.
The neuroimaging software FreeSurfer (http://surfer.nmr.mgh.harvard.edu) was used for segmentation of
striatal regions34. To limit multiple comparisons, D2R specific binding (BPND) for each ROI was averaged
across left and right hemispheres. Putamen and caudate D2R BPNDs were averaged to obtain a composite
dorsal striatal BPND and ventral striatal BPND included average nucleus accumbens D2R BPND. The midbrain region was traced on each individual’s MPRAGE as previously described33.
Voxel-based Analyses. We conducted voxel-based analyses to determine whether specific striatal

or midbrain clusters of D2R binding related to BMI or Eating Related to Emotion, Eating Related to
Reward, Non-food Reward, and Punishment behavioral domain scores. Images of D2R BPND across the
brain were generated for each participant and smoothed with a 6 mm full width at half maximum kernel.
These images were averaged across normal-weight and obese individuals and thresholded at BPND =  0 to
use as an explicit mask for regions including striatum or subcortical regions only. Positive and negative
associations between D2R binding and dependent variables were tested at the voxel level using SPM8
(http://www.fil.ion.ucl.ac.uk/spm).

Primary Statistical Analyses. Much of the data was managed using REDCap electronic data capture tools hosted by the Biostatistics Division of Washington University School of Medicine35. Group
demographic variables were compared with Pearson Chi Square, Mann Whitney U, or t-tests. Dorsal and
ventral striatal BPND were compared with repeated measures ANCOVA covarying for age, ethnicity, and
education. Midbrain D2R BPND and domain scores were compared between normal-weight and obese
groups with ANCOVAs covarying for age, ethnicity and education. Significant findings for a behavioral
domain were followed up with exploratory ANCOVAs of each questionnaire contributing to that domain.
Separate hierarchical linear regression models with appropriate covariates (age, ethnicity, education level,
and/or BMI) were used to analyze the ability of each variable of interest to predict striatal or midbrain
D2R BPND. These analyses also yielded partial correlations describing the unique variance contributed
by each variable of interest to BPND. For voxelwise analyses, correlations between D2R binding and BMI
and behavioral domain scores were calculated as Pearson’s r and tested for significance with Student’s
one-sample t-tests covaried for age, ethnicity, education, and, for behavioral domains, BMI, at each voxel.
For SPM analyses, p ≤  0.001, after multiple comparison correction, at voxelwise level was considered
significant. For all other analyses, significance level was set at α  ≤  0.05.

Results

Participant Characteristics. Normal-weight and obese groups are described in Table 1. We did not
have complete Non-food Reward and Punishment questionnaire datasets from one obese individual and
another obese individual did not undergo a PET scan. Therefore, analyzed data sets including these variables consist of 21 obese and 17 normal-weight individuals. One normal-weight participant’s midbrain
D2R BPND was too low to be quantified by our processing software and analyses including this variable
included 20 or 21 obese and 16 normal-weight participants.
BMI and Central D2R Specific Binding. As in our previous report on a subset of these individuals10, after covarying for age, ethinicity and education level, obese and normal-weight groups did
not differ in striatal BPND (normal weight mean total striatal BPND =  10.30, S.D. =  1.17; obese mean
total striatal BPND =  10.22, S.D. =  1.34; F1,33 =  1.98, p =  0.17). Across both groups, dorsal striatal D2R
BPND was greater than ventral striatal BPND at a marginally significant level (dorsal mean BPND =  4.09,
S.D. =  0.52; ventral mean BPND =  2.08, S.D. =  0.29; F1,33 =  3.87, p =  0.06) and there was no significant
interaction between group and striatal region (F1,33 =  1.98, p =  0.17). Midbrain D2R BPND was not different between normal-weight and obese groups (normal-weight mean BPND =  0.27, S.D =  0.14; obese
mean BPND =  0.27, S.D. =  0.09; F1,32 =  0.15, p =  0.70).
Scientific Reports | 5:11283 | DOI: 10.1038/srep11283
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Figure 1. BMI and striatal D2R are not significantly correlated across normal-weight (clear circles) and
obese (filled circles) groups. D2R specific binding was not correlated with BMI in the a, dorsal or b, ventral
striatum. Data points are standardized residuals of partial correlations after covarying for age, ethnicity and
education level. BPND, dopamine D2 receptor binding potential.

Controlling for age, ethnicity and education, BMI did not predict striatal BPND across all participants (dorsal R2 change =  0.07. F1,33 =  2.61, p =  0.12; ventral R2 change =  0.00. F1,33 =  0.02, p =  0.90)
(Fig. 1), or within either group (normal-weight: dorsal R2 change =  0.01; F1,12 =  0.19, p =  0.67, ventral
R2 change =  0.00. F1,12 =  0.002, p =  0.97; obese: dorsal R2 change =  0.03; F1,16 =  0.62, p =  0.44, ventral
R2 change =  0.04; F1,16 =  0.99, p =  0.33). Similarly, BMI did not predict midbrain D2R BPND across
normal-weight and obese participants (R2 change =  0.00. F1,32 =  0.001, p =  0.98) or within either group
(normal-weight: R2 change =  0.05; F1,11 =  0.55, p =  0.48; obese: R2 change =  0.12; F1,16 =  2.51, p =  0.13).

Obesity-associated Behavior.

Table 2 presents group mean (S.D.) summed z-scores for each domain
and raw scores for each questionnaire.
The obese group had higher mean domain scores on Eating Related to Emotion (F1,34 =  11.62, p <  0.01;
Fig. 2A) and Eating Related to Reward (F1,34 =  28.47, p <  0.001; Fig. 2B) and a lower mean domain score
on Non-food Reward (F1,33 =  5.37, p =  0.03; Fig. 2C). Punishment domain scores were higher in obese
relative to normal-weight at a marginally significant level (F1,33 =  3.69, p =  0.06; Fig. 2D).
Within the Eating Related to Emotion domain, scores on all three questionnaires were correlated
with each other (0.63 ≤  r39 ≤ 0.80, p <  0.001) and the obese group scored significantly higher than the
normal-weight group on EES (F1,33 =  6.42, p =  0.02) and DEBQ ES (F1,33 = 4.75, p =  0.04) and marginally significantly higher on STQ MAE (F1,33 = 3.48, p =  0.07). BMI was associated with the summed
domain score across the entire sample (r39 =  0.46, p <  0.01) but not when examined just within obese
(r22 =  − 0.24, p =  0.29) or normal-weight (r17 =  0.09, p =  0.74).
The z-scores on the three questionnaires included in the Eating Related to Reward domain were correlated with each other (r39 =  0.43, p ≤  0.01). The obese group scored higher on the BES (F1,34 =  19.57,
p <  0.001), STQ IC (F1,34 =  14.77, p =  0.001) and the FCI (F1,34 =  10.35, p =  0.003). BMI related to
the summed domain score in the entire sample (r39 =  0.37, p < 0.02) but not within obese (r22 =  0.07,
p =  0.78) or normal-weight (r17 =  − 0.03, p =  0.91).
Within the Non-food Reward domain, the individual questionnaires did not correlate (0.03 ≤  r38 ≤ 0.28,
p ≥  0.09). The obese group had a lower mean score than the normal-weight group on the behavioral approach subscale of the BIS/BAS (F1,33 =  6.47, p =  0.02). Groups did not differ significantly on any
of the other Reward domain scales (SPSRQ: F1,33 =  0.21, p =  0.65; TCI-R: F1,33 =  0.44, p =  0.51) except
at a marginally significant level on the GRAPES reward expectancy subscale (obese <  normal-weight,
F1,33 =  3.25, p =  0.08). BMI did not correlate significantly with the summed domain score in the entire
sample (r38 =  − 0.11, p = 0.51) or within normal-weight (r17 =  0.39, p =  0.12; Fig. 3A). However, BMI was
correlated with the reward summed domain score within obese (r21 =  0.54, p = 0.01; Fig. 3B).
Within the Punishment domain, scores on all questionnaires were correlated with each other
(0.54 ≤  r39 ≤ 0.79, p ≤  0.001). The obese group tended to score higher on the behavioral inhibition portion of the BIS/BAS (F1,33 =  3.11, p =  0.09) and the damage avoidance subscale of the TCI-R
(F1,33 =  3.17, p =  0.08) than the normal-weight group; these differences were marginally significant.
Obese and normal-weight groups did not differ on the punishment expectancy subscale of the GRAPES
(F1,33 =  1.10, p =  0.30) or sensitivity to punishment subscale of SPRSQ (F1,33 =  2.30, p =  0.14). BMI did
Scientific Reports | 5:11283 | DOI: 10.1038/srep11283
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Figure 2. Behaviors thought to be tightly coupled to dopamine signaling differ between normal-weight
and obese individuals. Obese individuals self-report higher rates of a, emotion- and b, reward-based
eating behavior, c, lower rates of non-food reward behavior, and d, higher rates of avoidance of punishment
relative to normal-weight individuals. Data points are standardized residuals of partial correlations after
controlling for age, ethnicity, and education level. *, **, ***, p ≤  0.05, 0.01, 0.001 relative to normal-weight.
For avoidance of punishment, p =  0.06 relative to normal-weight.

not correlate significantly with the summed domain score in the entire sample (r38 =  0.15, p = 0.37) or
within normal-weight (r17 =  0.21, p =  0.43) or obese (r21 =  − 0.35, p = 0.12) groups.

Obesity-associated Behavior and Central D2R BPND.

After covarying age, ethnicity, education level,
and BMI, the Eating Related to Emotion domain score related to dorsal striatal BPND (R2 change =  0.13.
F1,32 =  7.51, p =  0.01; partial r =  0.44; Fig. 4A) but Eating Related to Reward (R2 change =  0.02. F1,32 =  1.15,
p =  0.29), Non-food Reward (R2 change =  0.01. F1,31 =  0.31, p =  0.58) and Punishment (R2 change =  0.00.
F1,31 =  0.06, p =  0.81) domain scores did not. Within the Eating Related to Emotion domain, EES (R2
change =  0.08. F1,32 =  5.48, p =  0.03, partial r =  0.38), DEBQ ES (R2 change =  0.12. F1,32 =  6.88, p =  0.01,
partial r =  0.42) and STQ MAE (R2 change =  0.10. F1,32 =  4.48, p =  0.04, partial r =  0.35) scores were
associated with dorsal striatal BPND .
After covarying age, ethnicity, education level, and BMI, Eating Related to Emotion domain scores (R2
change =  0.11. F1,32 =  5.18, p =  0.03) related to ventral striatal BPND (Fig. 4B) but Eating Related to Reward
(R2 change =  0.05. F1,32 =  2.33, p =  0.14), Non-food Reward (R2 change =  0.00. F1,31 =  0.19, p =  0.67) and
Punishment (R2 change =  0.02. F1,31 =  0.72, p =  0.40) domain scores did not. Within the Eating Related to
Emotion domain, DEBQ ES (R2 change =  0.10. F1,32 =  4.71, p =  0.04, partial r =  0.36) scores significantly
correlated with ventral striatal BPND. STQ MAE (R2 change =  0.08. F1,32 =  3.93, p =  0.06; partial r =  0.33)
and EES (R2 change =  0.07. F1,32 =  3.17, p =  0.09; partial r =  0.33) scores correlated with ventral striatal
BPND at a marginally significant level.
After covarying age, ethnicity, education level, and BMI, midbrain D2R BPND was related to Eating
Related to Emotion domain scores (R2 change =  0.10. F1,31 =  4.88, p =  0.04; partial r =  0.37, Fig. 5A).
Within this domain, higher midbrain D2R BPND significantly related to higher EES (R2 change =  0.14.
F1,31 =  6.48, p =  0.02; partial r =  0.42) and DEBQ ES (R2 change =  0.09. F1,31 =  4.71, p =  0.04; partial r =  0.36) scores but was not related to STQ MAE (R2 change =  0.03. F1,31 =  1.23, p =  0.28) scores.
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Figure 3. Although the obese group self-reported lower rates of non-food reward behavior relative to
the normal-weight group, higher BMI was associated with higher rates of non-food reward behavior
within obese individuals. a, BMI and non-food reward behavior, a composite measure of reward-related
behavior including approach, expectancy and sensitivity towards reward stimuli other than food, was not
significantly associated with BMI in the normal-weight group. b, Across obese individuals, there was a
positive relationship between BMI and non-food reward behavior. BMI, body mass index.

Figure 4. Self-reported emotional eating correlates with striatal D2R binding independent of BMI
across normal-weight (clear circles) and obese (filled circles) individuals. Higher rates of emotionbased eating, a composite measure of self-reported tendency to eat to avoid negative emotion, was related
to higher a, dorsal and b, ventral striatal D2R across normal-weight and obese groups. Data points are
standardized residuals of partial correlations after controlling for age, ethnicity, education level, and BMI.
BPND, dopamine D2 receptor binding potential.

Midbrain D2R BPND was also related to Non-food Reward domain scores (R2 change =  0.13. F1,30 =  4.82,
p = 0.04; partial r =  0.37, Fig. 5B). Within the Non-food Reward domain, higher midbrain D2R BPND
related to higher scores on the BAS (R2 change =  0.10. F1,30 =  3.83, p =  0.06; partial r =  0.34) and reward
sensitivity subscale of the SPSRQ (R2 change =  0.09. F1,30 =  3.73, p =  0.06; partial r =  0.33) at marginally
significant levels but were not associated with scores on the reward expectancy subscale of the GRAPES
(R2 change =  0.01. F1,30 =  0.30, p = 0.59 ) or reward-related TCI-R scales (R2 change =  0.02. F1,30 =  0.78,
p =  0.38). Midbrain D2R BPND was not associated with Eating Related to Reward (R2 change =  0.00.
F1,31 =  0.01, p =  0.93) or Punishment (R2 change =  0.00. F1,3 =  0.05, p =  0.83) domain scores.

Scientific Reports | 5:11283 | DOI: 10.1038/srep11283

7

www.nature.com/scientificreports/

Figure 5. Midbrain D2R binding correlates with self-reported reward-related and eating behavior
independent of BMI across normal-weight (clear circles) and obese (filled circles) individuals. a,
Higher rates of non-food reward behavior, b composite measure of self-reported tendency to approach,
anticipate, and/or be sensitive to rewarding stimuli other than food, was related to higher midbrain D2R
across normal-weight and obese groups. a, Similar to striatal D2R binding, midbrain D2R binding positively
related to self-reported emotional eating. Data points are standardized residuals of partial correlations after
controlling for age, ethnicity, education level, and BMI. BPND, dopamine D2 receptor binding potential.

Voxel-based Analysis. While positive BPND-behavioral relationships appeared to be present in striatum and midbrain at less stringent criterion for statistical significance, there were no significant relationships observed between D2R binding and BMI or any of the behavioral domain scores at the voxel-wise
level (p >  0.001 for all tests).

Discussion

Our current findings contribute to the obesity and neuroimaging literature in several important ways.
First, we characterize four different types of putatively DA-related behavior in rigorously screened, moderately obese and normal-weight participants using well-validated and reliable questionnaires. To our
knowledge, no other study has investigated these behaviors simultaneously in obese and normal-weight
individuals to the same extent. Second, our D2R binding measurements are not confounded by D3R
binding and competition with endogenous DA because we used the relatively novel radioligand [11C]
NMB, which is unique due to its high affinity and selectivity for D2R that appears impervious to endogenous DA. These radioligand properties permit us to quantify D2R specific binding levels rather than
D2/D3R availability and avoid the influence of endogenous DA levels. Finally, we detected relationships between D2R binding and behavioral phenotypes, as measured by several validated and reliable
self-report questionnaires. These relationships were specific to two of four behavioral domains we investigated and were independent of BMI. Moreover, BMI itself did not correlate with D2R specific binding.
These data underscore the complex interaction among eating- and reward-related behavior, BMI, and
measures of a key central reward system (striatal and midbrain D2R specific binding). Our findings that
eating- and reward-related behavior linearly relate to striatal and midbrain D2R, respectively, support the
notion that regulation of food intake and reward-driven behavior involve a central reward, motor, and
habit formation system, even though D2R specific binding was not associated with BMI.
With our ROI-based analyses, we demonstrate that obesity-associated behavior, specifically
self-reported higher rates of eating to avoid negative emotion, correlates with higher striatal D2R binding in vivo across obese and normal-weight participants, independent of BMI. This finding is consistent
with the recent report that striatal D2/D3R availability is positively associated with a dimension of the
Three-factor Eating Questionnaire, ‘opportunistic eating’9, which reflects habitual, emotional, and situational susceptibility to disinhibited eating36. Our finding is consistent with theirs, but extends the results
by using several validated questionnaires related to emotional eating and a D2-selective radioligand.
Our results are also in line with those of a study that showed multi-locus genetic profile scores reflecting enhanced DA function (including the ANKK single nucleotide polymorphism associated with D2R
levels) relate to more emotional and binge eating37. Our findings differ from Volkow et al.38 in which
greater emotionality was associated with lower dorsal striatal D2/D3 receptor availability. However, only
nonobese participants were studied by Volkow et al.38 and screening criteria and the properties of the
PET radioligand used were different than those in our study. Although not statistically significant, higher
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dorsal striatal D2R binding in our sample tended to relate to higher BMI across normal-weight and
moderately obese individuals, similar to Dunn et al.8. Perhaps, as others propose1,6,7, striatal DA system
overactivity induced by repeated emotional overeating in less severe forms of overweight or obesity
eventually downregulates striatal D2/D3R, presenting as lower receptor availability in extremely obese
individuals as in Wang et al.4 and de Weijer et al2. Alternatively, obese individuals with relatively higher
striatal D2R binding may be protected from developing more severe forms of obesity. Unfortunately,
scanner weight-limits and size of the bore precluded inclusion of severely or morbidly obese individuals
in the current study. Future investigations should employ longitudinal and/or cross-sectional studies
to determine whether striatal D2R and obesity-associated behaviors change in accordance with large
changes in BMI (i.e. from moderate to severe obesity).
Our ROI-based analyses also showed that midbrain D2R binding related to self-reported emotional eating and non-food reward-related behavior in a positive manner across normal-weight and obese groups.
This is not surprising given the midbrain’s roles in motivation, habit formation39, and activity geared
towards obtaining reward40. Our results are in apparent contrast with those of Savage et al.19, in which
a negative relationship between novelty-seeking and substantia nigra D2/D3R availability, as measured
by [18F]fallypride, was observed in normal-weight but not obese individuals. However novelty-seeking
was not specifically addressed in our study – it comprised one subscale of the TCI-R questionnaire. In
addition, unlike the D2R-selective [11C]NMB, [18F]fallypride binds to both D2R and D3R and is sensitive to competition with endogenous DA41. Our results are in agreement with those of a previous study
in which higher trait motivation related to higher midbrain and ventral striatal D2/D3R availability
as measured by [11C]raclopride42. In our study, the relationship between midbrain D2R and non-food
reward-related behavior appears to be driven by scores on the BAS27 and the SPSRQ30, which are meant
to reflect responsivity to and drive for reward and reward sensitivity, respectively. In contrast to striatal
D2R, midbrain D2R are thought to be almost exclusively located presynaptically and, when activated
by DA transmission arising locally and from afferent projections, function as inhibitory receptors on
cell bodies and dendrites of dopaminergic neurons, resulting in decreased DA release in midbrain and
striatum43–46. Therefore, the midbrain may modulate DA transmission in mesostriatal reward circuitry
through this negative feedback loop45. Since we observed positive correlations between behavior and
D2R in both striatal and midbrain regions independent of BMI, our data indicate that D2R levels within
this reward pathway may reflect degree of motivation for or sensitivity to obtaining non-food reward and
alleviating negative emotions via eating in normal-weight and obese individuals. However, our findings
should be interpreted with caution since they are correlational and future studies may experimentally
test this hypothesis and alternative explanations.
Our moderately obese participants self-reported higher rates of emotion- and reward-based eating
behavior but less non-food reward behavior relative to normal-weight individuals. Obese individuals
also tended to self-report sensitivity to punishment to a greater extent than normal-weight individuals.
Other studies also show higher rates of eating due to emotional distress in obesity7,47–50 as well as positive
correlations between food-related reward behavior and BMI26,51–53. However, our results contrast with a
previous study that showed an inverse relationship between BMI and non-food reward behavior in obese
people54. Although our obese group reported lower rates of non-food reward behavior relative to the
normal-weight group, BMI was still positively related to non-food reward behavior within obese participants. One possible explanation for our finding is that while moderately obese individuals self-report
reduced non-food reward-based behavior relative to normal-weight participants, there remains a gradient in which both food and non-food reward sensitivity is greater in obese individuals with higher BMI.
Alternatively, there may be reward-insensitive and reward-sensitive subtypes of moderate obesity. Finally,
few studies have evaluated punishment-related behavior in obesity but Franken and Muris55 found no
significant correlation between sensitivity to punishment and food craving in participants ranging from
underweight to obese while another study demonstrated lower behavioral inhibition in obese individuals7. Taken together, our behavioral findings support the idea that obese individuals may experience
‘reward deficiency syndrome’56, in which over-consumption of food may compensate for reduced ability
to experience pleasure from other activities. Alternatively, RDS in obesity may be secondary to stronger
hedonic response to food in individuals with enhanced striatal DA function37, putting them at risk of
overeating and eventually overriding desire for other rewarding stimuli. Longitudinal investigation of
the effect of intervention-induced changes in BMI on reward-related behavior will help clarify this relationship.
There are some limitations to the current study. First, we urge caution in interpreting our findings
regarding relationships between central D2R binding and behavior because, admittedly, several hierarchical linear regression analyses were performed without stringent multiple comparisons correction.
However, our findings are supported by previous studies: Guo et al.9 detected a relationship of a similar
nature between dorsal D2/D3R binding and ‘opportunistic eating’ and the midbrain is known to function
as a modulator of motivation for food and non-food reward39–40,57. Still, due to the novel nature of our
findings and the small sample on which they are based, these results will require replication. Further,
we did not find any specific clusters of D2R binding within striatum or midbrain that related to eating
or reward-based behavior. Our voxelwise analyses was likely less sensitive to these relationships due to
variability in D2R binding at the voxelwise level; in contrast, the ROI-based analyses reduced variability
in these measures due to use of mean binding potential across regions that were eroded to minimize
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partial volume effects of neighboring regions known to have less D2R binding. Second, our results cannot
explain whether emotional eating or non-food reward behavior precedes higher central D2R binding or
vice versa, a key question in terms of understanding, preventing, or treating obesity. Also, due to time
constraints, we did not control for whether participants were fasted or sated while completing relevant
questionnaires and computer tasks. While this is an important factor to control for in the future, we cannot know how hunger state may have affected our results here since we did not ask participants to rate
satiety. In regards to the PET scan, [11C]NMB is not displaceable by endogenous DA and therefore D2R
binding potential should not be impacted by satiety state. Finally, this study was designed to obtain baseline striatal D2R binding in normal-weight and obese individuals unconfounded by health conditions
and medications that interact with or affect DA signaling. Consequently, our results do not generalize
to normal-weight or obese individuals with clinical diagnosis-level mental disorders thought to underlie
some types of eating behaviors that may involve DA signaling including depression, impulsivity, binge
eating and substance abuse. Effects of the interactions between obesity and these disorders on central
D2R are highly important and merit further investigation. Despite these limitations, our results offer a
template for testable hypotheses that address the limitations described.
In summary, relative to the normal-weight group, the obese group self-reported lower rates of non-food
reward behavior and higher rates of eating behavior related to negative affect, sensitivity to rewarding
properties of palatable foods, and sensitivity to punishment. Self-reported emotional eating positively
correlated with striatal and midrain D2R binding across normal-weight and obese individuals. Higher
rates of self-reported non-food reward-related behavior were associated with higher midbrain D2R binding. Taken together, our findings indicate that there are fundamental differences in self-reported eating
and reward-related behavior between normal-weight and obese individuals and that, across both groups
of individuals, D2R binding levels in the mesostriatal DA system may reflect degree of motivation to alleviate negative emotion through eating and for obtainment of non-food reward. Longitudinal investigations of how these variables interact and contribute to excessive body weight will help identify potential
pharmacological and behavioral targets for prevention and/or treatment of obesity.
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